根据 位华尔街分析师的预测,Invitro International 的收入预期范围从 $ 到 $
Invitro International 的盈利质量评分是多少?
Invitro International 的盈利质量评分为 B+/53.5046。该评分基于盈利能力、增长、现金生成与资本分配以及杠杆四个维度。
Invitro International 何时发布财报?
Invitro International 的下一份财报预计在 发布
Invitro International 的预期收益是多少?
根据华尔街分析师的预测,Invitro International 的预期收益为 $
Invitro International 是否超出收益预期?
Invitro International 最近的收益为 $, 预期。
关键数据
前收盘价
$0.0679
开盘价
$0.0611
当日区间
$0.0611 - $0.0679
52周范围
$0.0315 - $0.16
交易量
130
平均成交量
41.4K
股息收益率
--
每股收益(TTM)
0.00
市值
$1.5M
什么是 IVRO?
InVitro International engages in development and commercialization globally of test kits and laboratory services. The company is headquartered in Placentia, California. The Company’s testing technologies are designed to produce data regarding corrosivity, or ocular/dermal irritation, which correlate with animal and human test results. Its technologies are commercialized through test kits and laboratory services globally. The company operates in various industry segments providing in-vitro (non-animal) consumer, product and environmental safety test methods to customers in the cosmetics, personal care, household products, textiles, pharmaceuticals, chemicals, and hazardous waste transportation industries. Its Irritection Assay System is a vitro test method which uses changes of relevant macromolecules to predict the ocular and dermal irritancy of chemicals, mixtures and product formulations. Its Irritection Assay System consists of an ocular test, Ocular Irritection and dermal test, Dermal Irritection. Corrositex is a non-animal test that determines skin corrosivity.